July 6, 2022
by Andrii Buvailo, Irina Bilous
Biopharma insight
It took more than eight decades since the landmark experiments on calorie restrictions in 1930th to get to a point …
May 30, 2022
by Andrii Buvailo
Biopharma insight
Using virtual reality (VR) for manipulating 3D models of small molecules and large biomolecules in the context of drug design …
April 25, 2022
by Andrii Buvailo
Biopharma insight
What is “artificial intelligence”? Artificial intelligence (AI) is an interdisciplinary science concerned with building “intelligent agents”, the field which takes …
Jan. 24, 2022
by Chris De Savi
Biopharma insight
Antimicrobial resistance (AMR) poses a major threat to human health. There were an estimated 4.95M deaths associated with bacterial AMR …
Jan. 21, 2022
by Andrii Buvailo
Biopharma insight
In November 2021, the parent company of Google, Alphabet, Inc., announced the launch of a new commercial subsidiary in the …
Dec. 3, 2021
by Andrii Buvailo
Biopharma insight
Getting a step closer to treating Idiopathic Pulmonary Fibrosis A Hong Kong-based company applying a state-of-the-art artificial intelligence (AI) platform …
Aug. 9, 2021
by Andrii Buvailo
Biopharma insight
Table of Contents: Introduction Artificial intelligence (AI) in drug discovery yields breakthroughs The abundance of venture capital, major funding …
April 15, 2021
by Aruna Rajan
Biopharma insight
2020 was an unusual year, for the first time, venture funding for microbiome companies substantially exceeded grant funding for microbiome …
March 24, 2021
by Leo Cole
Biopharma insight
Did you know? According to a study from Accenture, 60% of patients would prefer access to care via telehealth technology …
Feb. 11, 2021
by Andrii Buvailo
Biopharma insight
A few decades ago, pharmaceutical giants did most of the discovery work in-house, along with every other work necessary to …
Nov. 29, 2020
by Andrii Buvailo
Biopharma insight
Table of Contents: Introduction The abundance of venture capital, major funding rounds New AI-driven biotech startups founded in 2020 Notable …
July 1, 2020
by David Shlaes
Biopharma insight
(This post originally appeared on David Shlaes's personal blog) The US FDA just published an analysis of antibiotic development looking back …